Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: CHKP stock price vs HUM: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at HUM's multiple
Needs HUM P/E.
Implied fair value · at CHKP's multiple
Needs CHKP P/E.
Live quote
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: CHKP FY 2025 (ended Dec 31, 2025) · HUM FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
CHECK POINT SOFTWARE TECHNOLOGIES LTD. · implied price per share
Bear
$44.43
Base
$52.28
Bull
$60.12
HUMANA INC · implied price per share
Bear
-$135.60
Base
-$159.53
Bull
-$183.46
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
1.68x
0.73x
Net debt / EBITDA
Leverage against operating earnings
2.99x
-1.78x
Cash and equivalents
Liquid reserves on the balance sheet
$1.80B
$19.90B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Palo Alto Networks Inc
CHKP vs PANW
Fortinet, Inc.
CHKP vs FTNT
Zscaler, Inc.
CHKP vs ZS
CrowdStrike Holdings, Inc.
CHKP vs CRWD
UNITEDHEALTH GROUP INC
CHKP vs UNH
Elevance Health, Inc.
CHKP vs ELV
CVS HEALTH Corp
CHKP vs CVS
Cigna Group
CHKP vs CI
CENTENE CORP
CHKP vs CNC
Oscar Health, Inc.
CHKP vs OSCR
$4.83B
$12.95B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
Based on an earlier data snapshot. Review the filing dates below or refresh after signing in.
If you believe CHKP can sustain its 30.5% operating margin and 38.8% net margin while continuing mid-single-digit growth, then CHKP looks attractive to own because it is cheaper on P/E than HUM and sits within its historical price band despite a supportive earnings-based implied price.
CHKP’s current price of $127.43 sits above the DCF range of $68.81-$93.09 but inside its historical band of $114.69-$140.17, suggesting the stock is not deeply distressed yet still looks supported by historical trading levels. The stated implied price of $355.06 from the P/E framework versus the current price implies 178.6% upside, but that comparison is not directly corroborated by HUM metrics because CHKP also trades at a much higher P/S than HUM.
Supporting Metrics
Live quote
